Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Narrative Mini-Review of Contemporary Evidence
Stereotactic body radiotherapy (SBRT) has evolved from an experimental ultrahypofractionation strategy into a guideline-endorsed standard-of-care option for localized prostate cancer, underpinned by the tumour’s low α/β ratio. Level 1 evidence from the PACE-B and HYPO-RT-PC trials establishes five- and seven-fraction r...